Law Offices of Thomas J. Lamb

  • About Firm
  • Practice Areas
  • Free Case Evaluation
  • Quick Contact Form
  • Frequently Asked Questions
  • Attorney Tom Lamb

Ozempic Vision Loss Lawsuits Against Novo Nordisk

May 6, 2025 By Law Offices of Thomas J. Lamb, P.A.

Patients who are filing Ozempic vision loss lawsuits against Novo Nordisk had developed nonarteritic anterior ischemic optic neuropathy (NAION) while using Ozempic. These cases are product liability failure to warn lawsuits filed against the responsible drug company, Novo Nordisk, because the Ozempic drug label does not warn about NAION as a … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), Ozempic, Rybelsus, vision loss, Wegovy

Vision Loss Linked to Rybelsus and Ozempic Use by Diabetes Patients

April 15, 2025 By Law Offices of Thomas J. Lamb, P.A.

The relatively new drug safety issue of vision loss linked to Rybelsus and Ozempic was the subject of a recent medical study that had this stated Objective, or purpose: “To investigate the association between semaglutide use and the risk of NAION among patients with diabetes.” On March 27, 2025, the JAMA Ophthalmology medical journal published … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), Ozempic, Rybelsus, vision loss

Ozempic Vision Loss Due to Increased Risk of NAION

December 20, 2024 By Law Offices of Thomas J. Lamb, P.A.

Here is the most recent development concerning Ozempic vision loss and blindness: The European Union’s drug regulator said it would assess two new Danish studies that link Novo Nordisk’s popular diabetes drug Ozempic to a rare eye disease. The studies published earlier this week had found Ozempic significantly increases the risk of type 2 … [Read more...]

Filed Under: Unsafe Drugs Tagged With: blindness, Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), Ozempic, Rybelsus, vision loss, Wegovy

Syfovre Claims: Vision Loss and Blindness: Law / Legal

August 27, 2024 By Law Offices of Thomas J. Lamb, P.A.

Syfovre claims for vision loss and blindness involving retinal vasculitis diagnosed after a patient’s first Syfovre injection are being filed as drug injury lawsuits. The basis for these product liability Syfovre lawsuits is the drug company Apellis Pharmaceuticals failed to warn about retinal vasculitis as a side effect until it revised the … [Read more...]

Filed Under: Unsafe Drugs Tagged With: blindness, retinal vasculitis, Syfovre, vision loss

Ozempic Side Effects Include Eye Problems With Possible Vision Loss

July 18, 2024 By Law Offices of Thomas J. Lamb, P.A.

In July 2024 we learned from a recent medical study that Ozempic side effects include eye problems with possible vision loss. More specifically, nonarteritic anterior ischemic optic neuropathy (NAION) has been linked to semaglutide — the active ingredient in Ozempic as well as Wegovy and Rybelsus. As such, this finding about the new NAION Ozempic … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), Ozempic, Rybelsus, vision loss, Wegovy

Syfovre: Eye Problems After Injection of Syfovre (pegcetacoplan)

April 26, 2024 By Law Offices of Thomas J. Lamb, P.A.

This blog post is about a 78-year-old woman with Syfovre eye problems involving vision loss in the first part of 2023. This Syfovre side effects case was reported in “Retinal vasculitis following intravitreal pegcetacoplan administration”, a medical journal article that appeared in the March 2024 edition of the American Journal of Ophthalmology … [Read more...]

Filed Under: Unsafe Drugs Tagged With: eye inflammation, occlusive retinal vasculitis, retinal vasculitis, Syfovre, vision loss

Syfovre Eye Injury Cases Update One Year After First Reports: “Uncertain”

April 8, 2024 By Law Offices of Thomas J. Lamb, P.A.

Beginning in April 2023, there have been reports of Syfovre eye injury cases, including retinal vasculitis resulting in significant vision loss. As of the beginning of April 2024, however, retina specialists seem to agree that both the etiology and the incidence rate of retinal vasculitis after Syfovre injections remain uncertain. Put in more … [Read more...]

Filed Under: Unsafe Drugs Tagged With: retinal vasculitis, Syfovre, vision loss

Syfovre Eye Injuries Decreased Vision For Patients After Syfovre Treatments

March 8, 2024 By Law Offices of Thomas J. Lamb, P.A.

Members of the American Society of Retina Specialists (ASRS) Research and Safety in Therapeutics (ReST) Committee recently issued a general report on cases where Syfovre eye injuries decreased vision for patients after Syfovre treatments. In summary, this report revealed that at least 13 patients had Syfovre retinal-related vision loss in … [Read more...]

Filed Under: Unsafe Drugs Tagged With: occlusive retinal vasculitis, retinal vasculitis, Syfovre, vision loss

Syfovre Vision Side Effects Cases Reported at Ophthalmology Meeting

November 15, 2023 By Law Offices of Thomas J. Lamb, P.A.

A Syfovre vision side effects cases presentation was one of the most important at the 2023 Annual Meeting of the American Academy of Ophthalmology (AAO) in San Francisco in early November. William J. Johnson, M.D., of the Wolfe Clinic in Iowa, reported on Syfovre vision side effects cases ranging from hemorrhagic occlusive vasculitis-type … [Read more...]

Filed Under: Uncategorized, Unsafe Drugs Tagged With: blindness, eye inflammation, occlusive retinal vasculitis, Syfovre, vision loss

Syfovre Eye Injections Adverse Reactions Update August 2023

August 23, 2023 By Law Offices of Thomas J. Lamb, P.A.

We have some new information about Syfovre eye injections adverse reactions causing vision loss and blindness from Apellis Pharmaceuticals and the American Society of Retina Specialists (ASRS). Apellis Pharmaceuticals said that it has confirmed seven cases of Syfovre eye injections adverse reactions. More specifically, these Syfovre vision loss … [Read more...]

Filed Under: Unsafe Drugs Tagged With: occlusive retinal vasculitis, retinal vasculitis, Syfovre, vision loss

  • 1
  • 2
  • 3
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

DrugInjuryLaw.com

DrugInjuryWatch.com

Asbestos-Mesothelioma.com

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Disclaimer and Copyright Notices
  • Sitemap

Copyright © 2025 · Law Offices of Thomas J. Lamb, P.A.